| Literature DB >> 34961809 |
Eugene S Jang1, Michael G Artin2, Venkat Boddapati2, Chung Min Chan1, Andre R Spiguel1, C Parker Gibbs1, Mark T Scarborough1, Wakenda K Tyler2.
Abstract
BACKGROUND: The complexity of sarcoma surgery often justifies surgical assistants of higher levels of academic training: senior residents, fellows, or co-surgeons. The association between the level of training of assistants and outcomes of these procedures has yet to be studied.Entities:
Year: 2021 PMID: 34961809 PMCID: PMC8710164 DOI: 10.1155/2021/2645737
Source DB: PubMed Journal: Sarcoma ISSN: 1357-714X
Baseline patient characteristics, stratified by trainee presence.
| No trainee | Trainee |
| |
|---|---|---|---|
|
|
| ||
| Age | 56 (37–73) | 52 (35–65) | 0.34 |
| Male sex | 13 (54.2%) | 81 (60.0%) | 0.65 |
| Race | 0.55 | ||
| White | 18 (75.0%) | 102 (75.6%) | |
| Black | 2 (8.3%) | 11 (8.1%) | |
| Asian | 2 (8.3%) | 4 (3.0%) | |
| Other and unreported | 2 (8.3%) | 18 (13.3%) | |
| Body mass index (BMI) | 27.94 (5.07) | 28.52 (6.18) | 0.66 |
| Hypertension | 3 (12.5%) | 52 (38.5%) | 0.02 |
| Diabetes | 0 (0.0%) | 14 (10.4%) | 0.13 |
| Smoker | 5 (20.8%) | 29 (21.5%) | 1.00 |
| Alcohol use | 1 (4.2%) | 1 (0.7%) | 0.28 |
| Cardiac comorbidity | 1 (4.2%) | 6 (4.4%) | 1.00 |
| Previous PCI | 0 (0.0%) | 3 (2.2%) | 1.00 |
| Previous cardiac surgery | 1 (4.2%) | 2 (1.5%) | 0.39 |
| History of angina | 0 (0.0%) | 1 (0.7%) | 1.00 |
| History of PVD | 0 (0.0%) | 1 (0.7%) | 1.00 |
| Pulmonary comorbidity | 0 (0.0%) | 8 (5.9%) | 0.61 |
| Dyspnea | 0 (0.0%) | 6 (4.4%) | 0.59 |
| History of COPD | 0 (0.0%) | 2 (1.5%) | 1.00 |
| Neurologic comorbidity | 0 (0.0%) | 9 (6.7%) | 0.36 |
| Hemiplegia | 0 (0.0%) | 1 (0.7%) | 1.00 |
| History of TIA | 0 (0.0%) | 1 (0.7%) | 1.00 |
| History of CVA with deficit | 0 (0.0%) | 2 (1.5%) | 1.00 |
| History of CVA without deficit | 0 (0.0%) | 2 (1.5%) | 1.00 |
| Tumor in CNS | 0 (0.0%) | 4 (3.0%) | 1.00 |
| Wound comorbidity | 1 (4.2%) | 18 (13.3%) | 0.31 |
| Preoperative wound infection | 0 (0.0%) | 7 (5.2%) | 0.60 |
| Wound classification other than “Clean” | 1 (4.2%) | 13 (9.6%) | 0.70 |
| Hematologic comorbidity | 3 (12.5%) | 13 (9.6%) | 0.71 |
| Bleeding disposition | 2 (8.3%) | 8 (5.9%) | 0.65 |
| Transfusion of ≥1 U of whole/packed RBCs in 72 hr prior to surgery | 1 (4.2%) | 5 (3.7%) | 1.00 |
| ASA classification | 1.38 (0.58) | 1.51 (0.71) | 0.38 |
| Functional status other than “Independent” | 0 (0.0%) | 5 (3.7%) | 1.00 |
| >10% loss of body weight in last 6 months | 0 (0.0%) | 8 (5.9%) | 0.61 |
| Disseminated cancer | 5 (20.8%) | 34 (25.2%) | 0.80 |
| Preoperative chemotherapy or radiation | 5 (20.8%) | 34 (25.2%) | 0.80 |
| Chemotherapy for malignancy in <=30 days pre-op | 2 (8.3%) | 28 (20.7%) | 0.25 |
| Radiotherapy for malignancy in <=90 days pre-op | 3 (12.5%) | 10 (7.4%) | 0.42 |
| Steroid use for chronic condition | 0 (0.0%) | 5 (3.7%) | 1.00 |
| Prior operation in <=30 days pre-op | 0 (0.0%) | 3 (2.2%) | 1.00 |
| Days from hospital admission to operation | 1.74 (±2.47) | 2.77 (±2.68) | 0.35 |
| Emergency surgery | 1 (4.2%) | 1 (0.7%) | 0.28 |
| Malignancy | 16 (66.7%) | 113 (83.7%) | 0.084 |
| Lower extremity surgery | 13 (54.2%) | 102 (75.6%) | 0.046 |
| General anesthesia | 23 (95.8%) | 127 (94.1%) | 1.00 |
| Total wRVUs | 28.36 (±2.04) | 42.51 (±1.76) | 0.002 |
Data are presented as mean (SD) for “Body Mass Index,” or geometric mean (±geometric SD) for “Days from hospital admission to operation” and “Total wRVUs,” or median (IQR) for “Age,” and n (%) for categorical measures. Student's t-test was used for “Body Mass Index” and “ASA class,” the Wilcoxon rank-sum test was used for other continuous measures, and Fisher's exact test was used for categorical measures. The following baseline variables tracked by the ACS NSQIP database had no occurrences in this cohort and are excluded from the table: history of congestive heart failure, history of myocardial infarction, peripheral vascular disease with rest pain, ventilator dependence, preoperative pneumonia, preoperative coma, impaired sensorium, paraplegia, quadriplegia, and preoperative sepsis. CVA = cerebrovascular accident, TIA = transient ischemic attack, PCI = percutaneous cardiac intervention, PVD = peripheral vascular disease, COPD = chronic obstructive pulmonary disease, CNS = central nervous system, and wRVUs = work relative value units. p < 0.05.
Univariable surgical outcomes stratified by trainee presence.
| No trainee | Trainee |
| |
|---|---|---|---|
|
|
| ||
| Any complication | 4 (16.7%) | 54 (40.0%) | 0.037 |
| Medical complication | 4 (16.7%) | 49 (36.3%) | 0.065 |
| Pneumonia | 0 (0.0%) | 1 (0.7%) | 1.00 |
| Unplanned reintubation | 0 (0.0%) | 0 (0.0%) | |
| Pulmonary embolism | 0 (0.0%) | 4 (3.0%) | 1.00 |
| Acute renal failure | 0 (0.0%) | 0 (0.0%) | |
| Urinary tract infection | 0 (0.0%) | 1 (0.7%) | 1.00 |
| Stroke/CVA | 0 (0.0%) | 0 (0.0%) | |
| Coma | 0 (0.0%) | 0 (0.0%) | |
| Peripheral nerve injury | 0 (0.0%) | 1 (0.7%) | 1.00 |
| Cardiac arrest | 0 (0.0%) | 0 (0.0%) | |
| Myocardial infarction | 0 (0.0%) | 0 (0.0%) | |
| Blood transfusion | 2 (8.3%) | 43 (31.9%) | 0.025 |
| Deep vein thrombosis | 0 (0.0%) | 3 (2.2%) | 1.00 |
| Sepsis | 2 (8.3%) | 3 (2.2%) | 0.16 |
| Septic shock | 0 (0.0%) | 0 (0.0%) | |
| Surgical complication | 2 (8.3%) | 9 (6.7%) | 0.67 |
| Superficial incisional surgical site infection | 0 (0.0%) | 1 (0.7%) | 1.00 |
| Deep incisional surgical site infection | 2 (8.3%) | 3 (2.2%) | 0.16 |
| Organ/space surgical site infection | 0 (0.0%) | 2 (1.5%) | 1.00 |
| Wound dehiscence | 0 (0.0%) | 3 (2.2%) | 1.00 |
| Unplanned reoperation | 0 (0.0%) | 7 (5.2%) | 0.60 |
| Unplanned readmission | 0 (0.0%) | 9 (6.7%) | 0.36 |
| Death | 0 (0.0%) | 2 (1.5%) | 1.00 |
| Total operation time in minutes | 125.42 (±2.34) | 208.39 (±2.09) | 0.003 |
| Length of total hospital stay in days | 3.41 (±2.79) | 6.30 (±2.50) | 0.006 |
Data are presented as geometric mean (±geometric SD) for continuous measures and n (%) for categorical measures. The Wilcoxon rank-sum test was used for continuous measures, and Fisher's exact test was used for categorical measures. CVA = cerebrovascular accident. p < 0.05.
Multivariable logistic regression analysis showing odds of any complication with trainee presence.
| Adjusted OR | 95% CI |
| |
|---|---|---|---|
| Resident presence | 2.336 | 0.636–8.586 | 0.201 |
| Age | 0.998 | 0.973–1.024 | 0.868 |
| Hematologic comorbidity | 2.812 | 0.823–9.612 | 0.099 |
| Preoperative chemotherapy or radiation | 3.433 | 1.340–8.795 | 0.010 |
| ASA class | 0.916 | 0.456–1.837 | 0.804 |
| Total wRVUs | 1.028 | 1.011–1.046 | 0.002 |
| Lower extremity surgery | 4.393 | 1.525–12.656 | 0.006 |
CI = confidence interval, ASA = American Society of Anesthesiologists, and wRVUs = work relative value units. p < 0.05.
Univariable and multivariable fractional logistic regression analyses of trainee participation and complication severity.
| Univariable beta (95% CI) |
| Multivariable beta (95% CI) |
| |
|---|---|---|---|---|
| Trainee presence | 0.711 (−0.481–1.902) | 0.243 | 0.488 (−0.685–1.661) | 0.415 |
| Age | — | — | 0.002 (−0.015–0.020) | 0.791 |
| Hematologic comorbidity | — | — | −0.141 (−1.024–0.741) | 0.754 |
| Pre-op chemotherapy/radiation | — | — | 0.210 (−0.448–0.868) | 0.532 |
| ASA class | — | — | −0.237 (−0.640–0.165) | 0.248 |
| Total wRVUs | — | — | 0.011 (0.006–0.017) | <0.001 |
| Lower extremity surgery | — | — | 0.492 (−0.571–1.555) | 0.365 |
There was no significant association between of resident presence and severity of complications found, as measured by the SWORD score (the severity weighting of postoperative adverse events in orthopedic surgery). CI = confidence interval, ASA = American Society of Anesthesiologists, and wRVUs = work relative value units. p < 0.05.
Figure 1Predicted complication severity for orthopedic oncology procedures without and with resident/fellow trainees (a). As a point of comparison, the average complication severity for the procedures with the lowest and highest average SWORD score in the literature (anterior compression, decompression, and fusion (ACDF) of the spine and hip fracture surgery, respectively) (b).